Skip to main content
Dryad logo

Identification and clinical associations of three forms of circulating T-cadherin in human serum

Citation

Fukuda, Shiro; Kita, Shunbun (2021), Identification and clinical associations of three forms of circulating T-cadherin in human serum, Dryad, Dataset, https://doi.org/10.5061/dryad.fqz612jr2

Abstract

Context: T-cadherin (T-cad) is a glycosylphosphatidylinositol (GPI)-anchored cadherin that mediates adiponectin to induce exosome biogenesis and secretion, protect cardiovascular tissues, promote muscle regeneration, and stimulate therapeutic heart protection by transplanted mesenchymal stem cells. CDH13, the gene locus of T-cad, affects plasma adiponectin levels most strongly, in addition to affecting cardiovascular disease risk and glucose homeostasis. Recently, it has been suggested that T-cad exists in human serum, although the details are still unclear.

Objective: To validate the existence of T-cad forms in human serum and investigate the association with clinical parameters of type 2 diabetes patients.

Methods: Using newly developed monoclonal antibodies against T-cad, pooled human serum was analyzed, and novel T-cad enzyme-linked immunosorbent assays (ELISAs) were developed. The serum T-cad concentrations of 183 Japanese type 2 diabetes patients were measured in a cross-sectional observational study. The main outcome measure was the existence of soluble T-cad in human serum.

Results: There were 3 forms of soluble T-cad: a 130-kDa form with a prodomain, a 100-kDa mature form, and a 30-kDa prodomain in human serum. Using newly developed ELISAs to measure them simultaneously, we found that the 130-kDa form of T-cad positively correlated with plasma adiponectin (r = 0.28, P < .001), although a physiological interaction with adiponectin was not observed in serum. The unique 30-kDa prodomain was associated with several clinical parameters in diabetes patients.

Conclusion: We identified 3 novel forms of soluble T-cad. Their importance as disease markers and/or biomarkers of adiponectin function and the possible bioactivity of the respective molecules require further investigation.

Usage Notes

These datasets were originally registered for our data transparency in peer-review process. Some files were deleted on publishing our work due to the copyright restriction. The clinical datasets are NOT contained due to the ethical restriction. Please contact us when you need to re-use these datasets.

Funding

Grant-in-Aid for Scientific Research, Award: 19K08978,19K08980,19K09023,18H02863